{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:42:44Z","timestamp":1792078964883,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T00:00:00Z","timestamp":1366070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00296-013-2750-z","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T17:28:51Z","timestamp":1366046931000},"page":"1923-1932","source":"Crossref","is-referenced-by-count":95,"title":["Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus"],"prefix":"10.1007","volume":"33","author":[{"given":"Samir D.","family":"Bhangle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot D.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"2750_CR1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-0327(83)90022-8","volume":"5","author":"DA Lewis","year":"1983","unstructured":"Lewis DA, Smith RE (1983) Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord 5:319\u2013332","journal-title":"J Affect Disord"},{"key":"2750_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/10673229809000307","volume":"5","author":"ES Brown","year":"1998","unstructured":"Brown ES, Suppes T (1998) Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 5:239\u2013246","journal-title":"Harv Rev Psychiatry"},{"key":"2750_CR3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1819.2011.02260.x","volume":"65","author":"HA Kenna","year":"2011","unstructured":"Kenna HA, Poon AW, de los Angeles CP, Koran LM (2011) Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci 65:549\u2013560","journal-title":"Psychiatry Clin Neurosci"},{"key":"2750_CR4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM195307302490502","volume":"249","author":"LD Clark","year":"1953","unstructured":"Clark LD, Quarton GC, Cobb S, Bauer W (1953) Further observations on mental disturbances associated with cortisone, and ACTH therapy. N Engl J Med 249:178\u2013183","journal-title":"N Engl J Med"},{"key":"2750_CR5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1981.01780290105011","volume":"18","author":"MHM Ling","year":"1981","unstructured":"Ling MHM, Perry PJ, Tsuang MT (1981) Side effects of corticosteroid therapy. Arch Gen Psychiatry 18:471\u2013477","journal-title":"Arch Gen Psychiatry"},{"key":"2750_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000180176","volume":"10","author":"R Cade","year":"1973","unstructured":"Cade R, Spooner G, Schlein E, Pickering M, DeQuesada A, Holcomb A, Juncos L, Richard G, Shires D, Levin D, Hackett R, Free J, Hunt R, Fregly M (1973) Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 10:37\u201356","journal-title":"Nephron"},{"key":"2750_CR7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1176\/ajp.108.9.641","volume":"108","author":"HP Rome","year":"1952","unstructured":"Rome HP, Braceland FJ (1952) The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 108:641\u2013651","journal-title":"Am J Psychiatry"},{"key":"2750_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00006842-195307000-00002","volume":"15","author":"TH Glaser","year":"1953","unstructured":"Glaser TH (1953) Psychotic reactions induced by corticotrophin (ACTH) and cortisone. Psychosom Med 15:280\u2013291","journal-title":"Psychosom Med"},{"key":"2750_CR9","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington","edition":"4"},{"key":"2750_CR10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archinte.1950.00230160070006","volume":"86","author":"LJ Soffer","year":"1950","unstructured":"Soffer LJ, Levitt MF, Baehr G (1950) Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus. Arch Intern Med 86:558\u2013573","journal-title":"Arch Intern Med"},{"key":"2750_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1192\/bjp.164.1.109","volume":"164","author":"T Terao","year":"1994","unstructured":"Terao T, Mizuki T, Ohji T, Abe K (1994) Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroids. Br J Psychiatry 164:109\u2013111","journal-title":"Br J Psychiatry"},{"key":"2750_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0049-0172(73)90007-3","volume":"3","author":"M Baker","year":"1973","unstructured":"Baker M, Hadler NM, Whitaker JN, Dunner DL, Gerwin RD, Decker JL (1973) Psychopathology in systemic lupus erythematosus: II: relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Semin Arthr Rheum 3:111\u2013126","journal-title":"Semin Arthr Rheum"},{"key":"2750_CR13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1176\/ajp.142.3.354","volume":"142","author":"BD Jones","year":"1985","unstructured":"Jones BD, Chouinard G (1985) Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus. Am J Psychiatry 142:354\u2013355","journal-title":"Am J Psychiatry"},{"key":"2750_CR14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0306-4530(95)00031-3","volume":"21","author":"D Naber","year":"1996","unstructured":"Naber D, Sand P, Heigl B (1996) Psychopathological and neuropsychological effects of 8-days\u2019 corticosteroid treatment: a prospective study. Psychoneuroendocrinology 21:25\u201331","journal-title":"Psychoneuroendocrinology"},{"key":"2750_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2190\/BL97-BWFR-4QR0-CEY7","volume":"26","author":"SB Patten","year":"1996","unstructured":"Patten SB, Williams JVA, Love EJ (1996) Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics. Int J Psychiatry Med 26:15\u201324","journal-title":"Int J Psychiatry Med"},{"key":"2750_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/070674379504000214","volume":"40","author":"SB Patten","year":"1995","unstructured":"Patten SB, Williams JVA, Love EJ (1995) Self-reported depressive symptoms in association with medication exposures among medical inpatients: a cross-sectional study. Can J Psychiatry 40:264\u2013269","journal-title":"Can J Psychiatry"},{"key":"2750_CR17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0895-4356(90)90014-G","volume":"43","author":"LA Palinkas","year":"1990","unstructured":"Palinkas LA, Wingard DL, Barrett-Connor E (1990) Chronic illness and depressive symptoms in the elderly: a population-based study. J Clin Epidemiol 43:1131\u20131141","journal-title":"J Clin Epidemiol"},{"key":"2750_CR18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1176\/jnp.1.4.398","volume":"1","author":"JR Rundell","year":"1989","unstructured":"Rundell JR, Wise MG (1989) Causes of organic mood disorder. J Neuropsychiatry Clin Neurosci 1:398\u2013400","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2750_CR19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.38.10.1631","volume":"38","author":"SL Minden","year":"1988","unstructured":"Minden SL, Orav J, Schildkraut JJ (1988) Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 38:1631\u20131634","journal-title":"Neurology"},{"key":"2750_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1176\/appi.psy.42.6.461","volume":"42","author":"K Wada","year":"2001","unstructured":"Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, Akiyama K, Kuroda S (2001) Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 42:461\u2013466","journal-title":"Psychosomatics"},{"key":"2750_CR21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1192\/bjp.162.4.549","volume":"162","author":"RS Mullen","year":"1993","unstructured":"Mullen RS, Romans-Clarkson SE (1993) Behavioral sensitization and steroid-induced psychosis. Br J Psychiatry 162:549\u2013551","journal-title":"Br J Psychiatry"},{"key":"2750_CR22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(84)92528-5","volume":"I","author":"JA Greeves","year":"1984","unstructured":"Greeves JA (1984) Rapid onset steroid psychosis with very low dosage of prednisolone. Lancet I:1119\u20131120","journal-title":"Lancet"},{"key":"2750_CR23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00004583-199708000-00006","volume":"36","author":"I Turktas","year":"1997","unstructured":"Turktas I, Gucuyener K, Ozden A (1997) Medication-induced psychotic reaction. J Am Acad Child Adolesc Psychiatry 36:1017\u20131018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2750_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00005053-197904000-00006","volume":"167","author":"RCW Hall","year":"1979","unstructured":"Hall RCW, Popkin MK, Stickney SK, Gardner ER (1979) Presentation of the steroid psychoses. J Nerv Ment Dis 167:229\u2013236","journal-title":"J Nerv Ment Dis"},{"key":"2750_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200022020-00004","volume":"22","author":"SB Patten","year":"2000","unstructured":"Patten SB, Neutel I (2000) Corticosteroid-induced adverse psychiatric effects. Drug Saf 22:111\u2013122","journal-title":"Drug Saf"},{"key":"2750_CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00006842-195209000-00003","volume":"24","author":"T Lidz","year":"1952","unstructured":"Lidz T, Carter JD, Lewis BI, Surratt C (1952) Effects of ACTH and cortisone on mood and mentation. Psychosom Med 24:363\u2013377","journal-title":"Psychosom Med"},{"key":"2750_CR27","first-page":"69","volume":"2","author":"A Per\u00e9nyi","year":"1988","unstructured":"Per\u00e9nyi A, Frecska E, Bagdy G, R\u00e9vai K (1988) Panic attacks as a consequence of chronic corticosteroid therapy? Eur J Psychiatry 2:69\u201374","journal-title":"Eur J Psychiatry"},{"key":"2750_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2190\/1H08-R84A-30VD-F5RJ","volume":"15","author":"OG Cameron","year":"1985","unstructured":"Cameron OG, Addy RO, Malitz D (1985) Effects of ACTH and prednisone on mood: incidence and time of onset. Int J Psychiatry Med 15:213\u2013223","journal-title":"Int J Psychiatry Med"},{"key":"2750_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/089198878900200108","volume":"2","author":"JR Grigg","year":"1989","unstructured":"Grigg JR (1989) Prednisone mood disorder with associated catatonia. J Geriatr Psychiatry Neurol 2:41\u201344","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2750_CR30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1542\/peds.63.4.677","volume":"63","author":"BJ Sullivan","year":"1979","unstructured":"Sullivan BJ, Dickerman JD (1979) Steroid associated catatonia: report of a case. Pediatrics 63:677\u2013679","journal-title":"Pediatrics"},{"key":"2750_CR31","first-page":"369","volume":"141","author":"NR Varney","year":"1994","unstructured":"Varney NR, Alexander B, MacIndoe JH (1994) Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 141:369\u2013372","journal-title":"Am J Psychiatry"},{"key":"2750_CR32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0002-7138(09)60608-7","volume":"1","author":"JC Harris","year":"1986","unstructured":"Harris JC, Carel CA, Rosenberg LA, Joshi P, Leventhal BG (1986) Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Adolesc Psychiatry 1:120\u2013124","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2750_CR33","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.7326\/0003-4819-66-6-1144","volume":"66","author":"TC Hall","year":"1967","unstructured":"Hall TC, Choi OS, Abadi A, Krant MJ (1967) High-dose corticosteroid therapy in Hodgkin\u2019s disease and other lymphomas. Ann Intern Med 66:1144\u20131153","journal-title":"Ann Intern Med"},{"key":"2750_CR34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4065\/81.10.1361","volume":"81","author":"TP Warrington","year":"2006","unstructured":"Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361\u20131367","journal-title":"Mayo Clin Proc"},{"key":"2750_CR35","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/jama.1951.03670330030008","volume":"147","author":"RH Freyberg","year":"1951","unstructured":"Freyberg RH, Traeger CH, Patterson M, Squires W, Adams CH (1951) Problems of prolonged cortisone treatment for rheumatoid arthritis. JAMA 147:1538\u20131543","journal-title":"JAMA"},{"key":"2750_CR36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1997.tb48381.x","volume":"823","author":"OM Wolkowitz","year":"1997","unstructured":"Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S (1997) Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann NY Acad Sci 823:81\u201396","journal-title":"Ann NY Acad Sci"},{"key":"2750_CR37","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.147.10.1297","volume":"147","author":"OM Wolkowitz","year":"1990","unstructured":"Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D (1990) Cognitive effects of corticosteroids. Am J Psychiatr 147:1297\u20131303","journal-title":"Am J Psychiatr"},{"key":"2750_CR38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0002-9343(80)90358-7","volume":"68","author":"R Dixon","year":"1980","unstructured":"Dixon R, Christy N (1980) On the various forms of corticosteroid withdrawal syndrome. Am J Med 68:224\u2013230","journal-title":"Am J Med"},{"key":"2750_CR39","doi-asserted-by":"crossref","unstructured":"Lewis A, Fleminger JJ (1954) The psychiatric risk from corticotrophin and cortisone. Lancet i:383\u2013386","DOI":"10.1016\/S0140-6736(54)90926-5"},{"key":"2750_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004714-200202000-00009","volume":"22","author":"ES Brown","year":"2002","unstructured":"Brown ES, Suppes T, Khan DA, Carmody TJ (2002) Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 22:55\u201361","journal-title":"J Clin Psychopharmacol"},{"key":"2750_CR41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4088\/JCP.v61n0404","volume":"61","author":"K Wada","year":"2000","unstructured":"Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S (2000) Recurrent cases of corticosteroid induced-mood disorders: clinical characteristics and treatment. J Clin Psychiatry 61:261\u2013267","journal-title":"J Clin Psychiatry"},{"key":"2750_CR42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(55)90203-5","volume":"18","author":"JJ Bunim","year":"1955","unstructured":"Bunim JJ, Ziff M, McEwen C (1955) Evaluation of prolonged cortisone therapy in rheumatoid arthritis: a four year study. Am J Med 18:27\u201340","journal-title":"Am J Med"},{"key":"2750_CR43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0954-6820.1963.tb16519.x","volume":"173","author":"JB Nielson","year":"1963","unstructured":"Nielson JB, Drivsholm A, Fischer F, Brochner-Mortensen K (1963) Long term treatment with corticosteroids in rheumatoid arthritis. Acta Med Scand 173:177\u2013183","journal-title":"Acta Med Scand"},{"key":"2750_CR44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/bjo.54.6.394","volume":"54","author":"SS Heyreh","year":"1970","unstructured":"Heyreh SS, Watson PG (1970) Prednisolone-21-stearoylglycolate in scleritis. Br J Ophthalmol 54:394\u2013398","journal-title":"Br J Ophthalmol"},{"key":"2750_CR45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0033-3182(89)72293-3","volume":"30","author":"P Kershner","year":"1989","unstructured":"Kershner P, Wang-Cheng R (1989) Psychiatric side effects of steroid therapy. Psychosomatics 30:135\u2013139","journal-title":"Psychosomatics"},{"key":"2750_CR46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/cpt1972135part1694","volume":"13","author":"Boston Collaborative Drug Surveillance Program","year":"1972","unstructured":"Boston Collaborative Drug Surveillance Program (1972) Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694\u2013698","journal-title":"Clin Pharmacol Ther"},{"key":"2750_CR47","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/00004583-198811000-00010","volume":"27","author":"BG Bender","year":"1988","unstructured":"Bender BG, Lerner JA, Kollasch E (1988) Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 27:720\u2013725","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2750_CR48","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1001\/jama.1982.03330220031031","volume":"248","author":"SS Sharfstein","year":"1982","unstructured":"Sharfstein SS, Sack DS, Fauci AS (1982) Relationship between alternate day corticosteroid therapy and behavioral abnormalities. JAMA 248:2987\u20132989","journal-title":"JAMA"},{"key":"2750_CR49","doi-asserted-by":"crossref","unstructured":"Glynne-Jones R, Vernon CC, Bell G (1986) Is steroid psychosis preventable by divided doses. Lancet ii:1404","DOI":"10.1016\/S0140-6736(86)92051-9"},{"key":"2750_CR50","first-page":"1695","volume":"17","author":"AJ Wysenbeek","year":"1990","unstructured":"Wysenbeek AJ, Leibovici L, Zoldan J (1990) Acute central nervous system complications in patients after pulse steroid therapy in patients with systemic lupus erythematosus. J Rheumatol 17:1695\u20131696","journal-title":"J Rheumatol"},{"issue":"suppl","key":"2750_CR51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/03009748409103858","volume":"54","author":"FA Wollheim","year":"1984","unstructured":"Wollheim FA (1984) Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol 54(suppl):27\u201332","journal-title":"Scand J Rheumatol"},{"key":"2750_CR52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003088-199019020-00003","volume":"19","author":"BM Frey","year":"1990","unstructured":"Frey BM, Frey FJ (1990) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 19:126\u2013146","journal-title":"Clin Pharmacokinet"},{"key":"2750_CR53","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/070674379704200718","volume":"42","author":"R Finkenbine","year":"1997","unstructured":"Finkenbine R, Gill HS (1997) Case of mania due to prednisone\u2013clarithromycin interaction. Can J Psychiatry 42:778","journal-title":"Can J Psychiatry"},{"key":"2750_CR54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04980.x","volume":"1179","author":"OM Wolkowitz","year":"2009","unstructured":"Wolkowitz OM, Burke H, Epel ES, Reus VI (2009) Glucocorticoids: mood, memory, and mechanisms. Ann NY Acad Sci 1179:19\u201340","journal-title":"Ann NY Acad Sci"},{"key":"2750_CR55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","volume":"57","author":"H Ainiala","year":"2001","unstructured":"Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496\u2013500","journal-title":"Neurology"},{"key":"2750_CR56","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","volume":"58","author":"RL Brey","year":"2002","unstructured":"Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rinc\u00f3n I, Gronseth G, Rhine CB, Padilla P, McGlasson D (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58:1214\u20131220","journal-title":"Neurology"},{"key":"2750_CR57","first-page":"323","volume":"11","author":"M Kohen","year":"1993","unstructured":"Kohen M, Asherson RA, Gharavi AE, Lahita RG (1993) Lupus psychosis: differentiation from the steroid-induced state. Clin Exp Rheumatol 11:323\u2013326","journal-title":"Clin Exp Rheumatol"},{"key":"2750_CR58","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3899\/jrheum.081133","volume":"36","author":"JG Hanly","year":"2009","unstructured":"Hanly JG, Su L, Farewell V, McCurdy G, Fougere L, Thompson K (2009) Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 36:1449\u20131459","journal-title":"J Rheumatol"},{"key":"2750_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","volume":"41","author":"A Unterman","year":"2011","unstructured":"Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G (2011) Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthr Rheum 41:1\u201311","journal-title":"Semin Arthr Rheum"},{"key":"2750_CR60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0889-857X(21)00952-2","volume":"14","author":"WJ McCune","year":"1988","unstructured":"McCune WJ, Golbus J (1988) Neuropsychiatric lupus. Rheum Dis Clin North Am 14:149\u2013167","journal-title":"Rheum Dis Clin North Am"},{"key":"2750_CR61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1997.tb48379.x","volume":"823","author":"JG Hanly","year":"1997","unstructured":"Hanly JG, Liang MH (1997) Cognitive disorders in systemic lupus erythematosus: epidemiologic and clinical issues. Ann NY Acad Sci 823:60\u201368","journal-title":"Ann NY Acad Sci"},{"key":"2750_CR62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","author":"ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature","year":"1999","unstructured":"ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthr Rheum 42:599\u2013608","journal-title":"Arthr Rheum"},{"key":"2750_CR63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00296-007-0410-x","volume":"28","author":"S Appenzeller","year":"2008","unstructured":"Appenzeller S, Cendes F, Costallat LT (2008) Acute psychosis in systemic lupus erythematosus. Rheumatol Int 28:237\u2013243","journal-title":"Rheumatol Int"},{"key":"2750_CR64","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/ken260","volume":"47","author":"JM Pego-Reigosa","year":"2008","unstructured":"Pego-Reigosa JM, Isenberg DA (2008) Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology 47:1498\u20131502","journal-title":"Rheumatology"},{"key":"2750_CR65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/096120339400300107","volume":"3","author":"Y Matsukawa","year":"1994","unstructured":"Matsukawa Y, Sawada S, Hayama T, Usui H, Horie T (1994) Suicide in patients with systemic lupus erythematosus: a clinical analysis of seven suicidal patients. Lupus 3:31\u201335","journal-title":"Lupus"},{"key":"2750_CR66","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10067-008-0921-1","volume":"27","author":"AM Abdel-Nasser","year":"2008","unstructured":"Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM (2008) Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 27:1377\u20131385","journal-title":"Clin Rheumatol"},{"key":"2750_CR67","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/01.WNL.0000058904.94330.A7","volume":"61","author":"A Afeltra","year":"2003","unstructured":"Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Lagan\u00e0 B, Caccavo D, Ferri GM, Amoroso A, Francia A (2003) Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61:108\u2013110","journal-title":"Neurology"},{"key":"2750_CR68","first-page":"985","volume":"30","author":"G Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985\u2013992","journal-title":"J Rheumatol"},{"key":"2750_CR69","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/0961203310374338","volume":"19","author":"KY Fong","year":"2010","unstructured":"Fong KY, Thumboo J (2010) Neuropsychiatric lupus: clinical challenges, brain-reactive autoantibodies and treatment strategies. Lupus 19:1399\u20131403","journal-title":"Lupus"},{"key":"2750_CR70","doi-asserted-by":"crossref","unstructured":"Zandman-Goddard G, Chapman J, Shoenfeld Y (2007) Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthr Rheum 36:297\u2013315","DOI":"10.1016\/j.semarthrit.2006.11.003"},{"key":"2750_CR71","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/ard.48.12.1014","volume":"48","author":"WL Sibbitt","year":"1989","unstructured":"Sibbitt WL, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD (1989) Magnetic resonance and computed tomography imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 48:1014\u20131022","journal-title":"Ann Rheum Dis"},{"key":"2750_CR72","first-page":"395","volume":"17","author":"S Khoshbin","year":"1999","unstructured":"Khoshbin S, Glanz BI, Schur PH (1999) Neuropsychiatric syndromes in systemic lupus erythematosus: a new look. Clin Exp Rheumatol 17:395\u2013398","journal-title":"Clin Exp Rheumatol"},{"key":"2750_CR73","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12016-007-8052-z","volume":"34","author":"JJ Rhiannon","year":"2008","unstructured":"Rhiannon JJ (2008) Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management. Clin Rev Allergy Immunol 34:356\u2013360","journal-title":"Clin Rev Allergy Immunol"},{"key":"2750_CR74","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.1780370907","volume":"37","author":"SD Denburg","year":"1994","unstructured":"Denburg SD, Carbotte RM, Denburg JA (1994) Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthr Rheum 37:1311\u20131320","journal-title":"Arthr Rheum"},{"key":"2750_CR75","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/qjmed\/81.3.975","volume":"81","author":"DT Boumpas","year":"1991","unstructured":"Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE (1991) Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 81:975\u2013984","journal-title":"Q J Med"},{"key":"2750_CR76","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9343(99)80078-3","volume":"98","author":"CM Neuwelt","year":"1995","unstructured":"Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG (1995) Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 98:32\u201341","journal-title":"Am J Med"},{"key":"2750_CR77","first-page":"295","volume":"14","author":"PC Ramos","year":"1996","unstructured":"Ramos PC, Mendez MJ, Ames PR, Khamashta MA, Hughes GR (1996) Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol 14:295\u2013299","journal-title":"Clin Exp Rheumatol"},{"key":"2750_CR78","first-page":"432","volume":"26","author":"V Baca","year":"1999","unstructured":"Baca V, Lavalle C, Garc\u00eda R, Catal\u00e1n T, Sauceda JM, S\u00e1nchez G, Mart\u00ednez I, Ram\u00edrez ML, M\u00e1rquez LM, Rojas JC (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26:432\u2013439","journal-title":"J Rheumatol"},{"key":"2750_CR79","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0002-9343(75)90500-8","volume":"58","author":"JS Sergent","year":"1975","unstructured":"Sergent JS, Lockshin MD, Klempner MSL, Lipsky BA (1975) Central nervous system disease is systemic lupus erythematosus: therapy and prognosis. Am J Med 58:644\u2013654","journal-title":"Am J Med"},{"key":"2750_CR80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1212\/WNL.61.1.104","volume":"61","author":"SY Chau","year":"2003","unstructured":"Chau SY, Mok CC (2003) Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 61:104\u2013107","journal-title":"Neurology"},{"key":"2750_CR81","first-page":"395","volume":"33","author":"K Nishimura","year":"2008","unstructured":"Nishimura K, Harigai M, Omori M, Sato E, Hara M (2008) Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroimmunology 33:395\u2013403","journal-title":"Psychoneuroimmunology"},{"key":"2750_CR82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0163-8343(88)90085-0","volume":"10","author":"RT Joffe","year":"1988","unstructured":"Joffe RT, Denicoff KD, Rubinow DR, Tsokos G, Balow JE, Pillemer SE (1988) Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Gen Hosp Psychiatry 10:56\u201360","journal-title":"Gen Hosp Psychiatry"},{"key":"2750_CR83","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jama.1979.03290360027021","volume":"241","author":"WE Falk","year":"1979","unstructured":"Falk WE, Mahnke MW, Poskanzer DC (1979) Lithium prophylaxis of corticotrophin-induced psychosis. JAMA 241:1011\u20131012","journal-title":"JAMA"},{"key":"2750_CR84","first-page":"1467","volume":"128","author":"DG Blazer","year":"1976","unstructured":"Blazer DG, Petrie WM, Wilson WP (1976) Affective psychosis following renal transplant. Dis Nerv Syst 128:1467\u20131473","journal-title":"Dis Nerv Syst"},{"key":"2750_CR85","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/070674379403900327","volume":"39","author":"A Abbas","year":"1994","unstructured":"Abbas A, Stryra R (1994) Valproate prophylaxis against steroid induced psychosis. Can J Psychiatry 39:188\u2013189","journal-title":"Can J Psychiatry"},{"key":"2750_CR86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0163-8343(94)90086-8","volume":"16","author":"M Bloch","year":"1994","unstructured":"Bloch M, Gur E, Shalev A (1994) Chlorpromazine prophylaxis of steroid-induced psychosis. Gen Hosp Psychiatry 16:42\u201344","journal-title":"Gen Hosp Psychiatry"},{"key":"2750_CR87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3928\/0048-5713-19920901-12","volume":"22","author":"JM Davis","year":"1992","unstructured":"Davis JM, Leach A, Merk BS, Janicak PG (1992) Treatment of steroid psychosis. Psychiatr Ann 22:487\u2013491","journal-title":"Psychiatr Ann"},{"key":"2750_CR88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0033-3182(93)71910-6","volume":"34","author":"AA Wyszynski","year":"1993","unstructured":"Wyszynski AA, Wyszynski B (1993) Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sj\u00f6gren\u2019s syndrome. Psychosomatics 34:173\u2013177","journal-title":"Psychosomatics"},{"key":"2750_CR89","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/ajp.156.6.968","volume":"156","author":"ES Brown","year":"1999","unstructured":"Brown ES, Khan DA, Suppes T (1999) Treatment of corticosteroid induced mood changes with olanzapine. Am J Psychiatry 156:968","journal-title":"Am J Psychiatry"},{"key":"2750_CR90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/070674370204700423","volume":"47","author":"CC Dasilva","year":"2002","unstructured":"Dasilva CC, Murse MC, Vokey K (2002) Steroid induced psychosis treated with risperidone. Can J Psychiatry 47:388\u2013389","journal-title":"Can J Psychiatry"},{"key":"2750_CR91","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1542\/peds.2009-1815","volume":"125","author":"S Ularntinon","year":"2010","unstructured":"Ularntinon S, Tzuang D, Dahl G, Shaw RJ (2010) Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics 125:1241\u20131245","journal-title":"Pediatrics"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2750-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2750-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2750-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T21:37:01Z","timestamp":1644788221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2750-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2750"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2750-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}